GRAZI, GIAN LUCA
 Distribuzione geografica
Continente #
AS - Asia 17.276
NA - Nord America 10.398
EU - Europa 7.443
SA - Sud America 2.134
Continente sconosciuto - Info sul continente non disponibili 398
AF - Africa 356
OC - Oceania 322
Totale 38.327
Nazione #
US - Stati Uniti d'America 10.003
CN - Cina 6.140
SG - Singapore 4.657
RU - Federazione Russa 3.969
KR - Corea 2.123
IT - Italia 1.916
HK - Hong Kong 1.904
BR - Brasile 1.689
VN - Vietnam 1.023
IN - India 553
FR - Francia 434
AU - Australia 320
BD - Bangladesh 280
FI - Finlandia 250
CA - Canada 214
GB - Regno Unito 159
AR - Argentina 156
DE - Germania 151
NL - Olanda 145
IE - Irlanda 138
ID - Indonesia 117
NG - Nigeria 105
EC - Ecuador 99
JP - Giappone 89
BJ - Benin 71
IQ - Iraq 68
MX - Messico 62
CO - Colombia 61
SE - Svezia 51
TR - Turchia 49
ZA - Sudafrica 49
CH - Svizzera 47
PL - Polonia 37
AE - Emirati Arabi Uniti 33
PK - Pakistan 33
PY - Paraguay 33
VE - Venezuela 33
SA - Arabia Saudita 30
ES - Italia 29
UA - Ucraina 29
MA - Marocco 25
CL - Cile 22
CR - Costa Rica 21
IL - Israele 21
EG - Egitto 20
PE - Perù 20
TN - Tunisia 19
JM - Giamaica 18
AT - Austria 17
KE - Kenya 17
PH - Filippine 17
DZ - Algeria 16
UZ - Uzbekistan 16
JO - Giordania 15
HN - Honduras 14
MY - Malesia 14
AZ - Azerbaigian 12
BE - Belgio 12
LB - Libano 12
UY - Uruguay 12
NP - Nepal 11
SN - Senegal 11
CI - Costa d'Avorio 10
DO - Repubblica Dominicana 10
TT - Trinidad e Tobago 10
BH - Bahrain 9
BO - Bolivia 9
PR - Porto Rico 9
AL - Albania 8
LT - Lituania 8
SV - El Salvador 8
KZ - Kazakistan 7
BG - Bulgaria 6
BY - Bielorussia 6
GT - Guatemala 6
NI - Nicaragua 6
OM - Oman 6
TH - Thailandia 6
TW - Taiwan 6
BB - Barbados 5
CZ - Repubblica Ceca 5
RO - Romania 5
AM - Armenia 4
KG - Kirghizistan 4
PS - Palestinian Territory 4
XK - ???statistics.table.value.countryCode.XK??? 4
CY - Cipro 3
EE - Estonia 3
GE - Georgia 3
RS - Serbia 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BS - Bahamas 2
BZ - Belize 2
ET - Etiopia 2
GR - Grecia 2
HR - Croazia 2
KW - Kuwait 2
LC - Santa Lucia 2
ME - Montenegro 2
Totale 37.904
Città #
Singapore 3.773
Hefei 3.171
Ashburn 2.141
Seoul 2.119
Santa Clara 1.900
Hong Kong 1.610
San Jose 1.133
Council Bluffs 401
Milan 366
Ho Chi Minh City 363
Los Angeles 329
Melbourne 312
Kent 310
Lauterbourg 296
The Dalles 267
Hanoi 238
Rome 231
Moscow 220
Buffalo 212
Phoenix 207
Helsinki 198
Mumbai 185
Bengaluru 181
Beijing 161
West Jordan 158
São Paulo 156
Dublin 138
New York 126
Pune 123
Dallas 120
Abuja 105
Boardman 88
Tokyo 87
Amsterdam 81
Frankfurt am Main 80
Bologna 78
Da Nang 75
Cotonou 71
Florence 68
Seattle 64
Paris 60
Shanghai 58
Rio de Janeiro 55
Fairfield 54
Naples 53
Chicago 52
Jakarta 52
Figino 45
Miano 42
Turin 42
Hillsboro 41
Toronto 41
Bern 40
Brasília 40
Houston 40
Quito 39
Guangzhou 38
Haiphong 35
Johannesburg 34
Munich 33
Warsaw 33
Curitiba 32
Lappeenranta 32
Montreal 32
Orem 31
Belo Horizonte 30
Brooklyn 28
Guayaquil 28
London 26
Shenzhen 26
Tianjin 26
Atlanta 25
Salt Lake City 25
North Bergen 24
Newark 23
Biên Hòa 22
Dhaka 22
Hải Dương 22
Istanbul 22
Salvador 22
Bogotá 21
Campinas 21
Romola 21
St Louis 21
Woodbridge 21
Cambridge 20
Genoa 19
Palermo 19
Porto Alegre 19
Verona 19
Bicester 18
Boston 17
Denver 17
Mexico City 17
Padua 17
Pompano Beach 17
Ribeirão Preto 17
Sorocaba 17
Washington 17
Baghdad 16
Totale 23.738
Nome #
Regret affects the choice between neoadjuvant therapy and upfront surgery for potentially resectable pancreatic cancer 262
Hepatectomy for Metabolic Associated Fatty Liver Disease (MAFLD) related HCC: Propensity case-matched analysis with viral- and alcohol-related HCC 224
REDISCOVER International Guidelines on the Perioperative Care of Surgical Patients With Borderline-resectable and Locally Advanced Pancreatic Cancer 211
Experimental Evaluation of a New Perfusion Machine using Normothermic Cycles on Explanted Livers 209
Absence of neuroinvasive disease in a liver transplant recipient who acquired West Nile virus (WNV) infection from the organ donor and who received WNV antibodies prophylactically 207
Liver resection with thrombectomy as a treatment of hepatocellular carcinoma with major vascular invasion: results from a retrospective multicentric study 206
Is minimally invasive liver surgery a reasonable option in recurrent HCC? A snapshot from the I Go MILS registry 192
Intraperitoneal drain placement and outcomes after elective colorectal surgery: international matched, prospective, cohort study 187
Preoperative prediction of post hepatectomy liver failure after surgery for hepatocellular carcinoma on CT-scan by machine learning and radiomics analyses 186
A bioluminescent mouse model of proliferation to highlight early stages of pancreatic cancer: A suitable tool for preclinical studies 176
KRAS-related miR-143 expression is associated with lymph node involvement and correlates with outcome in pancreatic adenocarcinoma patients 176
Systemic fungemia and hepatic localizations of Fusarium solani in a liver transplanted patient: An emerging fungal agent 175
Adjuvant, adoptive immunotherapy with tumor infiltrating lymphocytes plus interleukin-2 after radical hepatic resection for colorectal liver metastases: 5-year analysis 173
Survival Benefit After Liver Transplantation: A Single European Center Experience 172
Secondo corso integrato di Stadiazione e Trattamento delle metastasi epatiche. San Leo(PU) 9 settembre 2005 172
Hepatitis C virus recurrence after liver transplantation: A 10-year evaluation 169
Liver Resection vs Nonsurgical Treatments for Patients With Early Multinodular Hepatocellular Carcinoma 167
A new liver transplant priority for patients with hepatocellular carcinoma 163
Aberrant Notch3 and Notch4 expression in human hepatocellular carcinoma 160
Multiple hepatocellular carcinoma: Long-term outcomes following resection beyond actual guidelines. An Italian multicentric retrospective study 159
A revised consideration on the use of very aged donors for liver transplantation 158
Corso integrato di stadiazione e trattamento delle metastasi epatiche. Reggio Emilia 8 novembre 2004 154
Outcome of Right Hepatectomies in Patients Older Than 70 Years 153
Mucocele del dotto cistico residuo non ostruttivo. Rivalutazione della complicanza negli ultimi 13 anni della nostra esperienza nei trapianti di fegato 150
Recommendations for management of patients with neuroendocrine liver metastases 149
Perspectives from Italy during the COVID-19 pandemic: nationwide survey-based focus on minimally invasive HPB surgery 148
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis 148
A case report of giant hepatic hemangioma spontaneous regression in adult, non-cirrhotic patient and literature review 147
17. Other Malignant Primary Tumors of the Liver 147
Cholangiocarcinoma landscape in Europe: diagnostic, prognostic and therapeutic insights from the ENSCCA Registry 146
Efficacy of MELD score in predicting survival after liver retransplantation 146
Complications in Post-Liver Transplant Patients 146
A contemporary view on vascular resections and reconstruction during hepatectomies 145
Hepatectomy Versus Sorafenib in Advanced Nonmetastatic Hepatocellular Carcinoma: A Real-life Multicentric Weighted Comparison 145
Wnt3a/b-Catenin signaling conditions differentiation of partially exhausted T-effector cells in human cancers 144
12-month follow-up data from a multicentre, prospective study of ccyclosporine C2 monitoring versus tacrolimus in liver transplant (LIS2T) 144
Comprehensive surgical intestinal rescue and transplantation program in adult patients: Bologna experience 141
Alfa-fetoprotein in hepatocellular carcinoma (HCC): diagnostic and prognostic role, clinical and biological predictors. Analysis of 1099 patients 140
Liver resection for hepatocellular carcinoma in cirrhotics and noncirrhotics. Evaluation of clinicopathologic features and comparison of risk factors for long-term survival and tumour recurrence in a single centre 140
A Novel Nomogram to Predict the Prognosis of Patients Undergoing Liver Resection for Neuroendocrine Liver Metastasis: an Analysis of the Italian Neuroendocrine Liver Metastasis Database 140
Medication compliance after liver transplantation: the importance of family support 139
DCLK1, a putative novel stem cell marker in human cholangiocarcinoma 139
Hepatocellular carcinoma in patients with cryptogenic cirrhosis 136
A partnership model between high- And low-volume hospitals to improve results in hepatobiliary pancreatic surgery 136
Indocyanine Green and Hepatobiliary Surgery: An Overview of the Current Literature 135
IRON: A retrospective international multicenter study on robotic versus laparoscopic versus open approach in gallbladder cancer 134
A new priority policy for patients with hepatocellular carcinoma awaiting liver transplantation within the model for end-stage liver disease system 134
Italian experience in adult clinical intestinal and multivisceral transplantation: 6 years later 133
Differential diagnosis in Rosai-Dorfman disease: A rare case of isolated hepatic presentation mimicking a metastatic tumor with positive 18-FDG uptake 133
The actin modulator hMENA regulates GAS6-AXL axis and pro-tumor cancer/stromal cell cooperation 133
Surveillance for hepatocellular carcinoma in elderly italian patients with cirrhosis. Effects on cancer staging and patients survival 132
The COVID - AGICT study: COVID-19 and advanced gastro-intestinal cancer surgical treatment. A multicentric Italian study on the SARS-CoV-2 pandemic impact on gastro-intestinal cancers surgical treatment during the 2020. Analysis of perioperative and short-term oncological outcomes 132
A Pan-Cancer Analysis of Enhancer Expression in Nearly 9000 Patient Samples 132
The Immune Landscape of Cancer 131
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics 131
Liver transplantation for recurrent hepatocellular carcinoma on cirrhosis after liver resection: University of Bologna experience 130
Genomic and Functional Approaches to Understanding Cancer Aneuploidy 129
Is portal hypertension a contraindication to hepatic resection? 128
Italian Clinical Practice Guidelines on Cholangiocarcinoma - Part II: Treatment 128
Impaired degradation of YAP1 and IL6ST by chaperone-mediated autophagy promotes proliferation and migration of normal and hepatocellular carcinoma cells 128
12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus 127
A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-β Superfamily 127
Key components of a hepatobiliary surgery curriculum for general surgery residents: results of the FULCRUM International Delphi consensus 126
ALPPS for primary and secondary liver tumors 126
Results of intestinal and multivisceral transplantation in adult patients: Italian experience 125
Machine Learning Predictive Model to Guide Treatment Allocation for Recurrent Hepatocellular Carcinoma After Surgery 125
Liver transplantation from hepatitis B surface antigen positive donors: A safe way to expand the donor pool 123
Pre-operative liver biopsy in cirrhotic patients with early hepatocellular carcinoma represents a safe and accurate diagnostic tool for tumor grading assessment 122
MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality 122
Results of surgical therapy for hilar cholangiocarcinoma: a single-center experience 122
MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality 122
Upfront Surgery vs. Endoscopic Stenting Bridge to Minimally Invasive Surgery for Treatment of Obstructive Left Colon Cancer: Analysis of Surgical and Oncological Outcomes 122
Circulating and hepatic endocannabinoids and endocannabinoid-related molecules in patients with cirrhosis 121
Performance of comprehensive complication index and clavien‐dindo complication scoring system in liver surgery for hepatocellular carcinoma 121
Split-liver transplantation with pediatric donors: a multicenter experience 121
LAPAROSCOPIC VERSUS OPEN RESECTION FOR HEPATOCELLULAR CARCINOMA ACCORDING TO THE PROCEDURE’S COMPLEXITY: REAL-WORLD WEIGHTED DATA FROM A NATIONAL REGISTER 121
Diagnostic dilemmas in biliary strictures mimiking cholangiocarcinoma 121
Autonomic dysfunction and hyperdynamic circulation in cirrhosis with ascites 121
Comprehensive Characterization of Cancer Driver Genes and Mutations 121
Evidence of oxidative imbalance in long-term liver transplant patients 121
Early onset aggressive hereditary amyloidosis: report of an Italian family with TTR Arg47 mutation. 121
Six score systems to evaluate candidates with advanced cirrhosis for orthotopic liver transplant: Which is the winner? 121
CT-Based Radiomics Models with External Validation for Prediction of Recurrence and Disease-Specific Mortality After Radical Surgery of Colorectal Liver Metastases 120
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation 120
Association of polygenic risk score and bacterial toxins at screening colonoscopy with colorectal cancer progression: A multicenter case-control study 120
Multicohort and cross-platform validation of a prognostic Wnt signature in colorectal cancer 119
The pattern of hMENA isoforms is regulated by TGF-β1 in pancreatic cancer and may predict patient outcome 119
Orthotopic liver transplantation (OLT): contribution of diagnostic imaging and interventional radiology in preparing the transplantation and managing complications. Part 1: Indications, surgical technique, diagnostic imaging and interventional radiology before transplantation from cadaveric and living donor 119
Diffusion, outcomes and implementation of minimally invasive liver surgery: a snapshot from the I Go MILS (Italian Group of Minimally Invasive Liver Surgery) Registry 119
The Effect of a Liver Transplant Program on the Outcomes of Resectable Hepatocellular Carcinoma: A Nationwide Multicenter Analysis 119
Recurrent hepatitis C virus infection post liver transplantation: Impact of choice of calcineurin inhibitor 118
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer 118
Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation 117
Evolution of hepatitis B virus polymerase gene mutations in hepatitis B e antigen-negative patients receiving lamivudine therapy 117
Asbestos exposure in patients affected by bile duct tumours [Esposizione all'amianto in pazienti affetti da neoplasie delle vie biliari] 117
Anti-HBs re-seroconversion after liver transplantation in a patient with past HBV infection receiving a HBsAg positive graft 117
A prospective study on the neurological complications after liver transplantation 117
Improved results of liver resections for hepatocellular carcinoma on cirrhosis give the procedure added value 116
Prospective down-staging protocol for HCC not meeting the Milan criteria 116
A room for the alpps procedure in patients with HCC 116
Totale 14.153
Categoria #
all - tutte 129.666
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 129.666


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202256 0 0 7 0 2 2 3 5 3 6 11 17
2022/2023733 10 28 2 2 3 20 15 2 393 37 166 55
2023/20241.980 19 24 348 72 92 377 50 634 28 221 66 49
2024/202510.808 472 1.394 639 1.484 1.752 961 169 464 881 307 769 1.516
2025/202622.264 2.088 3.903 4.632 2.773 1.359 551 1.930 898 1.094 889 594 1.553
2026/20272.277 699 576 1.002 0 0 0 0 0 0 0 0 0
Totale 38.327